Table 3. Five-year-RSR of patients with MALT-lymphoma by sex and SEER summary stage between 2013 and 2017.
| SEER stage | All | Male | Female | |||
|---|---|---|---|---|---|---|
| No. | 5-year RSR | No. | 5-year RSR | No. | 5-year RSR | |
| Overall | 4,703 | 98.6 | 2,215 | 100.4 | 2,488 | 97.1 |
| Localized | 3,290 | 100.3a | 1,536 | 102.3 | 1,754 | 98.7 |
| Regional | 292 | 90.8 | 147 | 93.5 | 145 | 88.2 |
| Distant | 398 | 91.3 | 214 | 92.6 | 184 | 89.6 |
| Unknown | 723 | 97.9 | 318 | 99.5 | 405 | 96.6 |
SEER = Surveillance, Epidemiology, and End Results, RSR = relative survival rate, MALT-lymphoma = extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
aCalculated RSR can be more than 100%.